Enkei Wheels India Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 13, 2025, 10:52 pm

Quick Insight

Enkei Wheels India Ltd, with a share price of 498 and a market cap of 896 Cr., presents a mixed picture from a financial standpoint. The company's low P/E ratio and ROE of 1.06% indicate relatively weak profitability and returns on equity. Additionally, the ROCE of 3.94% suggests a suboptimal utilization of capital. However, the high promoter holding of 74.97% provides stability and aligns interests with shareholders. With a P/BV of 5.53x and an ICR of 4.79x, the company seems to be trading at a premium relative to its book value but has a healthy interest coverage ratio. Enkei Wheels India Ltd may benefit from improving operational efficiency to enhance profitability and shareholder value in the long term.

Competitors of Enkei Wheels India Ltd

All Competitor Stocks of Enkei Wheels India Ltd

Quarterly Result

Last Updated: May 31, 2025, 6:09 am

Below is a detailed analysis of the quarterly data for Enkei Wheels India Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 227.98 Cr.. The value appears strong and on an upward trend. It has increased from 195.20 Cr. (Dec 2024) to 227.98 Cr., marking an increase of 32.78 Cr..
• For Expenses, as of Mar 2025, the value is 216.81 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 187.35 Cr. (Dec 2024) to 216.81 Cr., marking an increase of 29.46 Cr..
• For Operating Profit, as of Mar 2025, the value is 11.17 Cr.. The value appears strong and on an upward trend. It has increased from 7.85 Cr. (Dec 2024) to 11.17 Cr., marking an increase of 3.32 Cr..
• For OPM %, as of Mar 2025, the value is 4.90%. The value appears strong and on an upward trend. It has increased from 4.02% (Dec 2024) to 4.90%, marking an increase of 0.88%.
• For Other Income, as of Mar 2025, the value is 0.14 Cr.. The value appears to be declining and may need further review. It has decreased from 5.37 Cr. (Dec 2024) to 0.14 Cr., marking a decrease of 5.23 Cr..
• For Interest, as of Mar 2025, the value is 5.08 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.75 Cr. (Dec 2024) to 5.08 Cr., marking an increase of 1.33 Cr..
• For Depreciation, as of Mar 2025, the value is 13.44 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 13.16 Cr. (Dec 2024) to 13.44 Cr., marking an increase of 0.28 Cr..
• For Profit before tax, as of Mar 2025, the value is -7.21 Cr.. The value appears to be declining and may need further review. It has decreased from -3.69 Cr. (Dec 2024) to -7.21 Cr., marking a decrease of 3.52 Cr..
• For Tax %, as of Mar 2025, the value is -26.49%. The value appears to be improving (decreasing) as expected. It has decreased from -19.78% (Dec 2024) to -26.49%, marking a decrease of 6.71%.
• For Net Profit, as of Mar 2025, the value is -5.30 Cr.. The value appears to be declining and may need further review. It has decreased from -2.97 Cr. (Dec 2024) to -5.30 Cr., marking a decrease of 2.33 Cr..
• For EPS in Rs, as of Mar 2025, the value is -2.95. The value appears to be declining and may need further review. It has decreased from -1.65 (Dec 2024) to -2.95, marking a decrease of 1.30.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 3:38 am

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: August 11, 2025, 3:54 pm

Below is a detailed analysis of the balance sheet data for Enkei Wheels India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Equity Capital, as of Jun 2025, the value is 9.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 9.00 Cr..
• For Reserves, as of Jun 2025, the value is 219.00 Cr.. The value appears to be declining and may need further review. It has decreased from 226.00 Cr. (Dec 2024) to 219.00 Cr., marking a decrease of 7.00 Cr..
• For Borrowings, as of Jun 2025, the value is 250.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 206.00 Cr. (Dec 2024) to 250.00 Cr., marking an increase of 44.00 Cr..
• For Other Liabilities, as of Jun 2025, the value is 157.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 122.00 Cr. (Dec 2024) to 157.00 Cr., marking an increase of 35.00 Cr..
• For Total Liabilities, as of Jun 2025, the value is 634.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 564.00 Cr. (Dec 2024) to 634.00 Cr., marking an increase of 70.00 Cr..
• For Fixed Assets, as of Jun 2025, the value is 341.00 Cr.. The value appears strong and on an upward trend. It has increased from 314.00 Cr. (Dec 2024) to 341.00 Cr., marking an increase of 27.00 Cr..
• For CWIP, as of Jun 2025, the value is 3.00 Cr.. The value appears to be declining and may need further review. It has decreased from 43.00 Cr. (Dec 2024) to 3.00 Cr., marking a decrease of 40.00 Cr..
• For Investments, as of Jun 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 3.00 Cr..
• For Other Assets, as of Jun 2025, the value is 288.00 Cr.. The value appears strong and on an upward trend. It has increased from 204.00 Cr. (Dec 2024) to 288.00 Cr., marking an increase of 84.00 Cr..
• For Total Assets, as of Jun 2025, the value is 634.00 Cr.. The value appears strong and on an upward trend. It has increased from 564.00 Cr. (Dec 2024) to 634.00 Cr., marking an increase of 70.00 Cr..

However, the Borrowings (250.00 Cr.) are higher than the Reserves (219.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Enkei Wheels India Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Dec 24, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Dec 23) which recorded 5.00.
• For Basic EPS (Rs.), as of Dec 24, the value is 1.48. This value is below the healthy minimum of 5. It has decreased from 6.51 (Dec 23) to 1.48, marking a decrease of 5.03.
• For Diluted EPS (Rs.), as of Dec 24, the value is 1.48. This value is below the healthy minimum of 5. It has decreased from 6.51 (Dec 23) to 1.48, marking a decrease of 5.03.
• For Cash EPS (Rs.), as of Dec 24, the value is 29.78. This value is within the healthy range. It has increased from 29.62 (Dec 23) to 29.78, marking an increase of 0.16.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Dec 24, the value is 122.17. It has increased from 120.95 (Dec 23) to 122.17, marking an increase of 1.22.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Dec 24, the value is 122.17. It has increased from 120.95 (Dec 23) to 122.17, marking an increase of 1.22.
• For Revenue From Operations / Share (Rs.), as of Dec 24, the value is 469.82. It has increased from 398.43 (Dec 23) to 469.82, marking an increase of 71.39.
• For PBDIT / Share (Rs.), as of Dec 24, the value is 37.34. This value is within the healthy range. It has decreased from 38.00 (Dec 23) to 37.34, marking a decrease of 0.66.
• For PBIT / Share (Rs.), as of Dec 24, the value is 9.04. This value is within the healthy range. It has decreased from 14.88 (Dec 23) to 9.04, marking a decrease of 5.84.
• For PBT / Share (Rs.), as of Dec 24, the value is 1.24. This value is within the healthy range. It has decreased from 8.93 (Dec 23) to 1.24, marking a decrease of 7.69.
• For Net Profit / Share (Rs.), as of Dec 24, the value is 1.48. This value is below the healthy minimum of 2. It has decreased from 6.51 (Dec 23) to 1.48, marking a decrease of 5.03.
• For PBDIT Margin (%), as of Dec 24, the value is 7.94. This value is below the healthy minimum of 10. It has decreased from 9.53 (Dec 23) to 7.94, marking a decrease of 1.59.
• For PBIT Margin (%), as of Dec 24, the value is 1.92. This value is below the healthy minimum of 10. It has decreased from 3.73 (Dec 23) to 1.92, marking a decrease of 1.81.
• For PBT Margin (%), as of Dec 24, the value is 0.26. This value is below the healthy minimum of 10. It has decreased from 2.24 (Dec 23) to 0.26, marking a decrease of 1.98.
• For Net Profit Margin (%), as of Dec 24, the value is 0.31. This value is below the healthy minimum of 5. It has decreased from 1.63 (Dec 23) to 0.31, marking a decrease of 1.32.
• For Return on Networth / Equity (%), as of Dec 24, the value is 1.20. This value is below the healthy minimum of 15. It has decreased from 5.37 (Dec 23) to 1.20, marking a decrease of 4.17.
• For Return on Capital Employeed (%), as of Dec 24, the value is 4.21. This value is below the healthy minimum of 10. It has decreased from 7.12 (Dec 23) to 4.21, marking a decrease of 2.91.
• For Return On Assets (%), as of Dec 24, the value is 0.47. This value is below the healthy minimum of 5. It has decreased from 2.19 (Dec 23) to 0.47, marking a decrease of 1.72.
• For Long Term Debt / Equity (X), as of Dec 24, the value is 0.55. This value is within the healthy range. It has increased from 0.51 (Dec 23) to 0.55, marking an increase of 0.04.
• For Total Debt / Equity (X), as of Dec 24, the value is 0.93. This value is within the healthy range. It has increased from 0.76 (Dec 23) to 0.93, marking an increase of 0.17.
• For Asset Turnover Ratio (%), as of Dec 24, the value is 1.54. It has increased from 1.39 (Dec 23) to 1.54, marking an increase of 0.15.
• For Current Ratio (X), as of Dec 24, the value is 1.07. This value is below the healthy minimum of 1.5. It has increased from 1.05 (Dec 23) to 1.07, marking an increase of 0.02.
• For Quick Ratio (X), as of Dec 24, the value is 0.62. This value is below the healthy minimum of 1. It has decreased from 0.65 (Dec 23) to 0.62, marking a decrease of 0.03.
• For Inventory Turnover Ratio (X), as of Dec 24, the value is 7.05. This value is within the healthy range. It has increased from 5.84 (Dec 23) to 7.05, marking an increase of 1.21.
• For Interest Coverage Ratio (X), as of Dec 24, the value is 4.79. This value is within the healthy range. It has decreased from 6.38 (Dec 23) to 4.79, marking a decrease of 1.59.
• For Interest Coverage Ratio (Post Tax) (X), as of Dec 24, the value is 1.19. This value is below the healthy minimum of 3. It has decreased from 2.09 (Dec 23) to 1.19, marking a decrease of 0.90.
• For Enterprise Value (Cr.), as of Dec 24, the value is 1,413.26. It has increased from 1,201.67 (Dec 23) to 1,413.26, marking an increase of 211.59.
• For EV / Net Operating Revenue (X), as of Dec 24, the value is 1.67. This value is within the healthy range. It has decreased from 1.68 (Dec 23) to 1.67, marking a decrease of 0.01.
• For EV / EBITDA (X), as of Dec 24, the value is 21.06. This value exceeds the healthy maximum of 15. It has increased from 17.60 (Dec 23) to 21.06, marking an increase of 3.46.
• For MarketCap / Net Operating Revenue (X), as of Dec 24, the value is 1.44. This value is within the healthy range. It has decreased from 1.46 (Dec 23) to 1.44, marking a decrease of 0.02.
• For Price / BV (X), as of Dec 24, the value is 5.53. This value exceeds the healthy maximum of 3. It has increased from 4.82 (Dec 23) to 5.53, marking an increase of 0.71.
• For Price / Net Operating Revenue (X), as of Dec 24, the value is 1.44. This value is within the healthy range. It has decreased from 1.46 (Dec 23) to 1.44, marking a decrease of 0.02.
• For EarningsYield, as of Dec 24, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.01 (Dec 23) to 0.00, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness